Live news related to GENFIT stock (FR0004163111): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on GENFIT mainly cover share price moves, analyst notes et earnings publications. The stock trades at €11,12 on Euronext Paris, down 2,46% at the last update. This page lists the articles published on GENFIT stock to track the share price, company announcements and any item likely to influence market perception.
The Lille-based biotech company specializing in hepatic and metabolic diseases rebounds sharply in mid-morning trading, while the Paris stock exchange…
The Lille-based biotech company specializing in hepatic and metabolic diseases experiences a sharp decline in mid-morning trading, alongside a broader…
The Lille biotech company specializing in hepatic and metabolic diseases achieves the best score on the Paris index, in a declining market. This rebou…
The Lille-based biotech company specializing in hepatic and metabolic diseases remains under pressure in mid-session trading, in a declining Paris mar…
The Lille-based biotech company specializing in hepatic and metabolic diseases is recovering in early afternoon trading, in a rising Paris market. Thi…
The Lille-based biotech company specializing in hepatic and metabolic diseases is declining again in mid-session, while the Paris market is rising sli…
The Lille-based biotech company specializing in hepatic and metabolic diseases rebounds sharply this Monday, among the strongest gains in the Paris in…
The Lille-based biotech is posting a modest rebound this morning after a month of severe correction. The movement occurs in a Paris market oriented to…
The Lille-based biotech retreats during midday trading and joins the bottom of the Paris index. The decline occurs in a French market under pressure, …
The Lille-based biotech remains under pressure in mid-morning trading and ranks among the weakest performers on the Paris index. The decline extends a…
